Andere talen C4X Discovery Holdings plc

Aandelen

Beurs gesloten - London S.E. Andere beurzen 17:46:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
12 ^GBX	+27,32%		+40,35%	+33,33%

25/04	C4X Discovery klaar voor vrijdag schrapping van notering op de AIM van de Londense beurs	MT
15/04	Aandeelhouders C4X Discovery stemmen in met privatisering bedrijf	AN

Norcros sells Johnson Tiles UK; Trifast trading well	25/04
C4X Discovery Set for Friday Delisting from London Bourse's AIM	25/04
C4X Discovery shareholders approve of taking firm private	15/04
AIM-listed biotech firms face crunch votes on future	15/04
C4X Discovery : Vernalis announces a drug discovery collaboration with C4X Discovery in inflammatory disease	08/04
Drug company C4X Discovery to de-list from London's AIM market	28/03
C4X Discovery seeks AIM delisting but half-year revenue skyrockets	27/03
C4X Discovery Seeks to Delist From London's AIM Amid Financial Markets Downturn	27/03
C4X Discovery : Delisting Circular	27/03
C4X Discovery : Interim Results 2024	27/03
Earnings Flash (C4XD.L) C4X DISCOVERY HOLDINGS Posts Fiscal H1 Revenue GBP24.6M	27/03
Earnings Flash (C4XD.L) C4X DISCOVERY HOLDINGS Reports Fiscal H1 EPS GBX7.06	27/03
C4X Discovery : Half-year results for the six months ended 31 January 2024	27/03
C4X Discovery Holdings plc Reports Earnings Results for the Half Year Ended January 31, 2024	27/03
C4X Discovery Holdings plc Announces Stepping Down of Mario Polywka as Non-Executive Director	18/01
Stocks down ahead of US Fed minutes	03/01
Stocks down before Fed minutes and US PMI data	03/01
AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals	03/01
Stocks mixed pre-Fed minutes, amid Asia losses	03/01
C4X receives USD11 million from AstraZeneca following NRF2 trials	03/01

Geen resultaten voor deze zoekopdracht